Jubilant Ingrevia Limited
NSE: JUBLINGREA · Specialty Chemicals · sector
₹606.00NSE close 2026-10-26
Key numbers
Market cap₹9,570 cr
Price₹606.00
52w high / low₹795 / ₹537
P/E31.0xSector median 22.6x
P/B3.1xSector median 2.6x
Book value₹197.9
Dividend yield0.82%Sector median 0.60%
ROE10.2%Sector median 10.6%
ROCE11.9%Sector median 12.9%
OPM13.1%Sector median 12.1%
Debt / equity0.25xSector median 0.18x
EV/EBITDA16.7xSector median 15.1x
Interest cover8.6x
Current ratio1.29x
Sales growth 3y-2.8%Sector median +5.0%
Profit growth 3y-3.3%Sector median +0.9%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹190 cr vs borrowings ₹792 cr (FY26): borrowings are higher by ₹602 cr.
- Borrowings rose in each of the last 3 years (₹397 cr → ₹792 cr).
- Operating profit covered interest 8.6x in the last 12 months.
- 9.11% of the promoters' shares are pledged (4.2% of all shares).
- Operating cash flow was below net profit in 1 of the last 5 years (FY22).
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Other income was 13% of net profit in the last 12 months.
- Debtor days went from 50 (FY24) to 65 (FY26).
- Dividend paid in 5 of the last 5 financial years.
- Price ₹606.00 on 2026-10-26: -23.8% from the 52-week high, +12.8% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹859.20 · low ₹541.30
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 |
| EBITDA | 124 | 138 | 147 | 142 | 136 | 114 | 163 | 199 |
| OPM % | 11.9% | 13.1% | 14.0% | 13.7% | 12.1% | 10.8% | 13.8% | 15.3% |
| Other income | 10 | 9 | 8 | 11 | 11 | 9 | 9 | 10 |
| Net profit | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 |
| EPS (₹) | 3.73 | 4.39 | 4.69 | 4.75 | 4.40 | 2.97 | 5.47 | 6.70 |
| Revenue YoY | +7.2% | -0.5% | +12.1% | +25.3% | ||||
| Profit YoY | +17.7% | -32.4% | +16.7% | +40.9% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 | 4,651 |
| EBITDA | 832 | 547 | 421 | 519 | 554 | 611 |
| Net profit | 477 | 308 | 183 | 251 | 278 | 309 |
| EPS (₹) | 29.98 | 19.34 | 11.56 | 15.89 | 17.59 | 19.54 |
| Revenue growth | -3.6% | -13.3% | +1.0% | +5.0% | +11.0% | |
| Profit growth | -35.5% | -40.5% | +37.3% | +10.6% | +11.2% | |
| Dividend / share (₹) | 2.85 | 5.00 | 5.00 | 5.00 | 5.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -2.8% | +45.0% | +11.0% |
| Net profit | -3.3% | +38.6% | +11.2% |
| EPS | -3.1% | -3.3% | – |
| Share price | – | -9.8% (2y) | -13.0% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 2,666 | 2,737 | 2,927 | 3,126 |
| Borrowings | – | 397 | 733 | 764 | 792 |
| Cash & equivalents | – | 85 | 80 | 115 | 190 |
| Total assets | – | 4,259 | 4,732 | 5,032 | 5,484 |
| Fixed assets | – | 1,788 | 2,478 | 2,558 | 3,148 |
| Capital work in progress | – | 525 | 331 | 525 | 154 |
| Investments | – | 3 | 10 | 14 | 26 |
| Receivables | – | 511 | 572 | 607 | 783 |
| Inventory | – | 1,035 | 941 | 943 | 880 |
| Payables | – | 801 | 767 | 815 | 941 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 453 | 462 | 430 | 508 | 524 |
| Cash from investing | -72 | -472 | -569 | -393 | -276 |
| Cash from financing | -418 | 42 | 144 | -129 | -155 |
| Capex | 230 | 481 | 568 | 366 | 299 |
| Free cash flow | 223 | -19 | -138 | 142 | 225 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 11.5% | 6.7% | 8.6% | 8.9% |
| ROCE % | – | 15.0% | 9.2% | 10.8% | 10.7% |
| Debtor days | – | 39 | 50 | 53 | 65 |
| Inventory days | – | 146 | 160 | 163 | 140 |
| Payable days | – | 113 | 131 | 141 | 150 |
| Cash conversion cycle (days) | – | 72 | 79 | 75 | 55 |
| Working capital days | – | 49 | 44 | 40 | 38 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 45.22% |
| FIIs | 6.94% |
| DIIs | 25.17% |
| of which Mutual funds | 22.59% |
| of which Insurance | 0.71% |
| Government | 0.02% |
| Public (non-institutions) | 21.69% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 51.47% | 51.47% | 45.22% | 45.22% | 45.22% | 45.22% | 45.22% | 45.22% |
| Promoter group | % |
|---|---|
| HSB Trustee Company PL HS Trustee Company PL | 19.00% |
| SPB Trustee Company PL SS Trustee Company PL | 18.36% |
| Miller Holdings PTE Ltd | 3.53% |
| MAV Management Advisors LLP | 3.15% |
| Priyavrat Bhartia | 0.88% |
| Hari Shanker Bhartia | 0.23% |
| Shamit Bhartia | 0.08% |
| Kavita Bhartia | 0.01% |
| Jaytee Private Limited | 0.00% |
| Nikita Resources Private Limited | 0.00% |
| Jubilant Enpro Private Limited | 0.00% |
| VAM Holdings Limited | 0.00% |
| Jubilant Consumer Private Limited | 0.00% |
| Jubilant Advisors LLP | 0.00% |
| Shyam Sunder Bhartia | 0.00% |
| Public holders above 1% | % |
|---|---|
| DSP Small CAP Fund | 6.37% |
| Kotak Small CAP Fund | 3.19% |
| Bandhan Small CAP Fund | 3.13% |
| Franklin India Small CAP Fund | 2.38% |
| HDFC Mutual Fund - HDFC Manufacturing Fund | 2.16% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small CAP Fund | 2.11% |
| Rekha Jhunjhunwala | 1.58% |
| Rekha Jhunjhunwala | 1.39% |
| Edelweiss Trusteeship Co Ltd AC- Edelweiss MF Ac-edelweiss Small CAP Fund | 1.32% |
| Investor Education and Protection Fund Authority Ministry of Corporate Affairs | 1.23% |
1,09,650 shareholders. Pledged: 9.11% of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| JUBLINGREA | ₹9,570 cr | 31.0x | 3.1x | 10.2% | 11.9% | 13.1% | -2.8% | 0.82% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Speciality Chemicals | ₹2,214 cr | 47.4% | ₹410 cr | 18.5% |
| Chemical Intermediates | ₹1,668 cr | 35.7% | ₹19 cr | 1.1% |
| Nutrition & Health Solutions | ₹790 cr | 16.9% | ₹79 cr | 10.0% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-24 | Dividend | Dividend - Rs 2.50 Per Share |
| 2026-02-10 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2025-07-25 | Dividend | Dividend - Rs 2.50 Per Share |
| 2025-02-03 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2024-08-02 | Dividend | Dividend - Rs 2.50 Per Share |
| 2024-02-09 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2023-08-10 | Dividend | Dividend - Rs 2.50 Per Share |
| 2023-02-10 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2022-08-23 | Dividend | Dividend - Rs 2.50 Per Share |
| 2022-02-10 | Dividend | Interim Dividend - Rs 2.50 Per Sh |
| 2021-08-05 | Dividend | Dividend - Rs 0.35 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Speciality Chemicals: Manufacturing, Distribution, Sales & Marketing
- Chemical Intermediates: Manufacturing, Distribution, Sales & Marketing
- Nutrition and Health Solutions: Manufacturing, Distribution, Sales & Marketing
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | JUBLINGREA |
| BSE code | 543271 |
| ISIN | INE0BY001018 |
| Face value | ₹1.0 |
| Incorporated | 2019-10-23 |
| Website | www.jubilantingrevia.com |
| Plants (India / abroad) | 6 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.